ArticleClinical and experimental pediatrics2026

High-dose methylprednisolone and tocilizumab improve survival of patients with high-risk pediatric acute necrotizing encephalopathy.

Chaonan Fan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.